SCHEMBL6346641

SCHEMBL6346641

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(S(=O)(=O)Nc2ccccc2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.58
AKR1C2 P52895 2/20 0.56
AKR1C1 Q04828 2/20 0.56
AKR1C4 P17516 1/20 0.56
AKR1C3 P42330 1/20 0.56
KDM1A O60341 1/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
SLC10A6 Q3KNW5 2/20 0.53
MAPT P10636 3/20 0.53
DHODH Q02127 1/20 0.52
KCNK2 O95069 1/20 0.51
KCNK10 P57789 1/20 0.51
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
ABL1 P00519 1/20 0.50
TSHR P16473 1/20 0.50
RIN1 Q13671 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350610 0.85 MEN1 (0.69) METAP2AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6349460 0.83 MEN1 (0.60) METAP2AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6352806 0.80 MEN1 (0.61) AKR1C2AKR1C1AKR1C4AKR1C3KMT2A
SCHEMBL6352359 0.80 METAP2 (0.71) METAP2AKR1C2AKR1C1KDM1AKMT2A
SCHEMBL6348358 0.80 METAP2 (0.71) METAP2KDM1AKMT2AMEN1SLC10A6
SCHEMBL9513479 0.79 MAPT (0.80) AKR1C2AKR1C1AKR1C4AKR1C3KMT2A
SCHEMBL17166275 0.79 AKR1C2 (0.73) AKR1C2AKR1C1AKR1C4AKR1C3KMT2A
SCHEMBL6349464 0.79 MEN1 (0.70) METAP2AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6352622 0.79 KCNK2 (0.59) METAP2AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6348852 0.78 AKR1C2 (0.72) AKR1C2AKR1C1AKR1C4AKR1C3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 METAP2 1269/4885AKR1C2 3012/4885AKR1C1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.